VIE Equity Snapshot

PTPN Weekly Equity Report

Pentixapharm Holding AG

Interactive chart JSON snapshot
Latest Close 2.39 EUR 12 Jun 2026
1W Return -0.4% latest completed week
4W Return 12.2% short-term follow-through
12W Return 29.5% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer based on Gallium-68, used to diagnose and monitor the progress of various diseases, including hematological and solid tumors, as well as endocrine, cardiovascular, and immunological disorders; and PentixaTher (PT-002), a therapeutic radiopharmaceutical based on Yttrium-90 and Lutetium-177, for the treatment of leukemia, which is in Phase 1/2 study; and develops diagnosis for functional adrenal tumors, which is in Phase II study. It also develops anti-GlycoTarget antibodies to treat solid tumors. In …

Snapshot

What the weekly tape is saying

PTPN closed the latest completed week at 2.39 EUR. The 4-week return is 12.2% and the 12-week return is 29.5%. Trend Signal is active, Market Dynamics is 0.72. Setup signature: Deep recovery attempt with a 57/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 22.6%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 63 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 100 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 71 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 8 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1.95 EUR
Vs Trend Line
22.6%
Fair Value
2.10 EUR
Vs Fair Value
14.0%
52W High
3.55 EUR
52W Low
1.33 EUR
Drawdown
-32.7%
Range Position
47.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.4%
4W 12.2%
12W 29.5%
26W 57.7%
52W -3.0%

Trend read

Active Streak
17 weeks
52W Active Weeks
17
52W Active Breadth
32.7%
Sector Scope
AT Healthcare
Sector Rank
54 of 112
Sector Percentile
52.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.72
4W MD Change
34150.8%
Relative Strength
3.02
4W RS Change
151.0%
Expectation
Undecided
Probability
48.99%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
247
52W Average
968
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.0%
52W Volatility
8.4%
Upside Weeks
20
Downside Weeks
31
Downside Breadth
59.6%
Avg Gain / Loss
6.9% / -4.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
69.9M

Opportunity signals

  • Trend Signal is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 2.39 EUR -0.4% 1.95 EUR 2.10 EUR 0.72 3.02 0 On
5 Jun 2026 2.40 EUR -4.0% 1.92 EUR 2.09 EUR 0.42 5.41 2.7K On
29 May 2026 2.50 EUR 14.2% 1.89 EUR 2.09 EUR 0.17 7.67 0 On
22 May 2026 2.19 EUR 2.8% 1.86 EUR 2.08 EUR 0.02 -3.96 0 On
15 May 2026 2.13 EUR 0.5% 1.84 EUR 2.08 EUR -0.00 -5.92 0 On
8 May 2026 2.12 EUR 3.9% 1.83 EUR 2.08 EUR 0.02 -8.09 0 On
1 May 2026 2.04 EUR -1.0% 1.82 EUR 2.08 EUR 0.06 -11.68 0 On
24 Apr 2026 2.06 EUR -1.9% 1.81 EUR 2.08 EUR 0.15 -11.80 0 On
17 Apr 2026 2.10 EUR 2.9% 1.80 EUR 2.08 EUR 0.21 -14.63 0 On
10 Apr 2026 2.04 EUR 1.0% 1.80 EUR 2.08 EUR 0.27 -16.43 0 On
3 Apr 2026 2.02 EUR 7.6% 1.78 EUR 2.08 EUR 0.40 -13.22 511 On
27 Mar 2026 1.88 EUR 1.7% 1.77 EUR 2.08 EUR 0.56 -17.99 0 On
20 Mar 2026 1.85 EUR -6.6% 1.77 EUR 2.08 EUR 0.80 -19.72 0 On
13 Mar 2026 1.98 EUR -2.7% 1.76 EUR 2.09 EUR 1.09 -16.70 0 On